内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by He Junli. Director active across 2 companies, notably Biostage, Inc.. Aggregated, 14 reports have been published. Split: 13 buys · 1 sell. Total volume traded: €132k. Activity tracked since 12 December 2022. The latest transaction was disclosed on 25 November 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to He Junli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
3,000 股@ US$1.703.4% 占其流量Common StockSEC:0001437749-25-036518:0
300 股@ US$1.980.4% 占其流量Common StockSEC:0001437749-25-030204:0
11,225 股@ US$1.8514.0% 占其流量Common StockSEC:0001437749-25-029783:0
4,050 股@ US$1.725.5% 占其流量Common StockSEC:0001437749-25-028095:0
2,299 股@ US$2.876.2% 占其流量Common StockSEC:0001437749-25-000007:0
5,101 股@ US$3.3715.0% 占其流量Common StockSEC:0001493152-24-036024:0
1,600 股@ US$2.804.1% 占其流量Common StockSEC:0001493152-24-025927:0
2,700 股@ US$4.7611.3% 占其流量Common StockSEC:0001493152-24-000226:0
900 股@ US$4.924.0% 占其流量Common StockSEC:0001493152-23-045302:0
1,500 股@ US$5.076.9% 占其流量Common StockSEC:0001493152-23-044357:0
1,500 股@ US$5.4314.0% 占其流量Common StockSEC:0001493152-23-032876:0
3,400 股@ US$4.6914.3% 占其流量Common StockSEC:0001493152-23-031566:0
8,000 股@ US$4.3230.9% 占其流量Common StockSEC:0001493152-23-030317:0
135 股@ US$6.83100.0% 占其流量Common StockSEC:0001415889-23-000497:0
About He Junli
He Junli is CEO of Harvard Apparatus Regenerative Technology, Inc. and a Director of Biostage, Inc. The record shows 14 filings in total, and across the 14 sampled filings from 2023-01-05 to 2025-12-01, buys total EUR 131520 and sells total EUR 876, with Acquisition listed as the modal transaction nature.